Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ellen, Voigt"'
Autor:
Ellen Voigt, Dawn E. Quelle
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13596 (2023)
Malignant peripheral nerve sheath tumors (MPNSTs) are deadly sarcomas, which desperately need effective therapies. Half of all MPNSTs arise in patients with neurofibromatosis type I (NF1), a common inherited disease. NF1 patients can develop benign l
Externí odkaz:
https://doaj.org/article/7036f8548f82452881bfd1ada986b996
Autor:
Michael S. Kareta, Yohannes Afeworki, Malini Mukherjee, Hunter Friesen, Moira McNally, Joshua Feiner, Kirtana Kumar, Ethan Thompson, Hannah Wollenzien, Madeline Wallenburg, Ellen Voigt
Antibodies used in this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41bd60fc9e88c483935973b41ebaaddf
https://doi.org/10.1158/1541-7786.22527660.v1
https://doi.org/10.1158/1541-7786.22527660.v1
Autor:
Michael S. Kareta, Yohannes Afeworki, Malini Mukherjee, Hunter Friesen, Moira McNally, Joshua Feiner, Kirtana Kumar, Ethan Thompson, Hannah Wollenzien, Madeline Wallenburg, Ellen Voigt
WGCNA network identification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04b09f0945fb97ce32bd7f5142ebb4bb
https://doi.org/10.1158/1541-7786.22527684.v1
https://doi.org/10.1158/1541-7786.22527684.v1
Autor:
Stacia L. Koppenhafer, Kelli L. Goss, Ellen Voigt, Emma Croushore, William W. Terry, Jason Ostergaard, Peter M. Gordon, David J. Gordon
Publikováno v:
Oncogene. 41:2873-2884
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f5093404c7a25cb27cb5d8a69e16713
https://doi.org/10.1038/s41388-022-02310-0
https://doi.org/10.1038/s41388-022-02310-0
Autor:
Jordan L Kohlmeyer, Courtney A Kaemmer, Joshua J Lingo, Ellen Voigt, Mariah R Leidinger, Gavin R McGivney, Amanda Scherer, Stacia L Koppenhafer, David J Gordon, Patrick Breheny, David K Meyerholz, Munir R Tanas, Rebecca D Dodd, Dawn E Quelle
Publikováno v:
Neuro-Oncology Advances. 4
Background Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with complex molecular and genetic alterations. Powerful tumor suppressors CDKN2A and TP53 are commonly disrupted along with NF1, a gene that encodes a negative regu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1dd3439e7bae0e9878e42d613ea7129
https://doi.org/10.1093/noajnl/vdac047
https://doi.org/10.1093/noajnl/vdac047
Autor:
Joshua Lingo, Jordan Kohlmeyer, Courtney Kaemmer, Amanda Scherer, Ellen Voigt, Michael Chimenti, Munir Tanas, Varun Monga, Ben Darbro, David Meyerholz, Rebecca Dodd, Dawn Quelle
Publikováno v:
Cancer Immunology Research. 10:A02-A02
Malignant peripheral nerve sheath tumors (MPNSTs) are deadly, Ras-driven sarcomas that lack effective therapies. Many tumors are unresectable and toxic chemotherapies are ineffectual. The sensitivity of MPNSTs to immune checkpoint blockade (ICB) ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2868aacfaf90aa0ed891fe11022a012c
https://doi.org/10.1158/2326-6074.tumimm22-a02
https://doi.org/10.1158/2326-6074.tumimm22-a02
Autor:
Ellen Voigt, Malini Mukherjee, Hunter Friesen, Yohannes Afeworki, Moira McNally, Michael S. Kareta, Kirtana Kumar, Ethan Thompson, Hannah Wollenzien, Madeline Wallenburg, Joshua Feiner
Publikováno v:
Mol Cancer Res
Although many cancer prognoses have improved in the past 50 years due to advancements in treatments, there has been little improvement in therapies for small-cell lung cancer (SCLC). One promising avenue to improve treatment for SCLC is to understand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373b119f98efbfa7ba758d3e384d7c0c
https://europepmc.org/articles/PMC8642303/
https://europepmc.org/articles/PMC8642303/
Autor:
Stacia L, Koppenhafer, Kelli L, Goss, Ellen, Voigt, Emma, Croushore, William W, Terry, Jason, Ostergaard, Peter M, Gordon, David J, Gordon
Publikováno v:
Oncogene. 41(20)
Sarcomas are difficult to treat and the therapy, even when effective, is associated with long-term and life-threatening side effects. In addition, the treatment regimens for many sarcomas, including Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c53429031f0deb25fa77afe93686ffd
https://pubmed.ncbi.nlm.nih.gov/35422476
https://pubmed.ncbi.nlm.nih.gov/35422476
Autor:
Joshua Feiner, Hannah Wollenzien, Vande Kamp M, Ellen Voigt, Michael S. Kareta, Ethan Thompson
Although many cancer prognoses have improved in the past fifty years due to advancements in treatments, there has been little to no improvement in therapies for small cell lung cancer (SCLC) which currently has a five-year survival rate of less than
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd659bb836decaa006778983e99441a
Autor:
Hannah Wollenzien, M.J. Vande Kamp, Ethan Thompson, Michael S. Kareta, Joshua Feiner, Ellen Voigt
Publikováno v:
Journal of Thoracic Oncology. 15:S35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f9aa612f54e4653a67877470150c0ef
https://doi.org/10.1016/j.jtho.2019.12.092
https://doi.org/10.1016/j.jtho.2019.12.092